Klaria Pharma Holding AB Logo

Klaria Pharma Holding AB

Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.

KLAR | ST

Overview

Corporate Details

ISIN(s):
SE0007280326
LEI:
529900YLMSNHNP7HOD11
Country:
Sweden
Address:
Virdings Allé 2, 754 50 UPPSALA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Klaria Pharma Holding AB is a pharmaceutical company that develops novel drug products based on its patented, proprietary alginate-based oral transmucosal film technology. This platform delivers active pharmaceutical ingredients directly into the bloodstream by adhering to the inside of the cheek, providing a non-invasive alternative to treatments currently available only as injections or nasal sprays. The company's strategy focuses on addressing significant patient needs where its technology offers clear advantages, such as improved convenience, safety, and efficacy. Klaria's development pipeline includes treatments for migraine (Sumatriptan), severe allergic reactions (Epinephrine), and organ transplant rejection (Sirolimus). The company also operates a subsidiary, Cannabis Delivery Sciences, which applies the film technology to cannabinoid-based products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Klaria Pharma Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Klaria Pharma Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
StemRIM Inc. Logo
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
Japan 4599
STENOCARE A/S Logo
Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.
Denmark STENO
ST PHARM CO., LTD. Logo
A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.
South Korea 237690
Sugentech, Inc. Logo
Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.
South Korea 253840
SUHEUNG CO.,LTD. Logo
Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.
South Korea 008490
Sumitomo Pharma Co., Ltd. Logo
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
Japan 4506
SunBio, Inc. Logo
Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.
South Korea 067370
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo
Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.
Japan 4582
SynAct Pharma Logo
Biotech developing oral therapies to resolve inflammation in diseases like rheumatoid arthritis.
Sweden SYNACT

Talk to a Data Expert

Have a question? We'll get back to you promptly.